Found: 19
Select item for more details and to access through your institution.
Genome‐wide association study of tau‐PET: Association of variant near NTNG2 with resistance to tau deposition: Neuroimaging: Imaging genetics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044321
- By:
- Publication type:
- Article
P3‐132: GENOME‐WIDE ASSOCIATION STUDY OF CEREBRAL MICROBLEEDS AND INFARCTION IDENTIFIES CANDIDATE GENES FOR VASCULAR RISK IN DEMENTIA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1118, doi. 10.1016/j.jalz.2018.06.1489
- By:
- Publication type:
- Article
Inherited genetics of adult diffuse glioma and polygenic risk scores—a review.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 4, p. 259, doi. 10.1093/nop/npac017
- By:
- Publication type:
- Article
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk.
- Published in:
- Nature Genetics, 2014, v. 46, n. 7, p. 731, doi. 10.1038/ng.3004
- By:
- Publication type:
- Article
A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation.
- Published in:
- Nature Genetics, 2012, v. 44, n. 10, p. 1122, doi. 10.1038/ng.2388
- By:
- Publication type:
- Article
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.
- Published in:
- Nature Genetics, 2009, v. 41, n. 8, p. 905, doi. 10.1038/ng.408
- By:
- Publication type:
- Article
8q24 clear cell renal cell carcinoma germline variant is associated with VHL mutation status and clinical aggressiveness.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Risk of Ovarian Cancer and Inherited Variants in Relapse-Associated Genes.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008884
- By:
- Publication type:
- Article
Experimental design of preclinical experiments: number of PDX lines vs subsampling within PDX lines.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 12, p. 2066, doi. 10.1093/neuonc/noab137
- By:
- Publication type:
- Article
Molecular profiling of long-term IDH-wildtype glioblastoma survivors.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 11, p. 1458, doi. 10.1093/neuonc/noz129
- By:
- Publication type:
- Article
Molecular subtyping of tumors from patients with familial glioma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 6, p. 810, doi. 10.1093/neuonc/nox192
- By:
- Publication type:
- Article
TELOMERE LENGTH VARIANTS ARE ASSOCIATED WITH HIGH-GRADE GLIOMA RISK: IDENTIFICATION OF A NOVEL GLIOMA RISK LOCUS BY GENOME-WIDE ASSOCIATION STUDY.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii2
- By:
- Publication type:
- Article
Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 8, p. 1041, doi. 10.1093/neuonc/not051
- By:
- Publication type:
- Article
Associations of High-Grade Glioma With Glioma Risk Alleles and Histories of Allergy and Smoking.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Associations of High-Grade Glioma With Glioma Risk Alleles and Histories of Allergy and Smoking.
- Published in:
- American Journal of Epidemiology, 2011, v. 174, n. 5, p. 574, doi. 10.1093/aje/kwr124
- By:
- Publication type:
- Article
Inherited variation in immune genes and pathways and glioblastoma risk.
- Published in:
- Carcinogenesis, 2010, v. 31, n. 10, p. 1770, doi. 10.1093/carcin/bgq152
- By:
- Publication type:
- Article
Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer's disease.
- Published in:
- Acta Neuropathologica, 2022, v. 143, n. 5, p. 571, doi. 10.1007/s00401-022-02419-2
- By:
- Publication type:
- Article
A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 3, p. 586, doi. 10.1002/cncr.27760
- By:
- Publication type:
- Article
Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin—a novel tumor checkpoint controller targeting microtubules.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 384, doi. 10.1093/neuonc/noab162
- By:
- Publication type:
- Article